185 results
8-K
EX-99.1
ADVM
Adverum Biotechnologies Inc
9 May 24
Adverum Biotechnologies Reports First Quarter 2024 Financial Results and Provides Pipeline Highlights
4:10pm
. Such statements include, but are not limited to, statements associated with the Company’s cash sufficiency and runway, potential benefits of Ixo-vec
8-K
EX-99.1
27dnvx
18 Mar 24
Adverum Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Pipeline Highlights and Corporate Updates
4:08pm
8-K
ynb52t7h 4s
8 Feb 24
Regulation FD Disclosure
8:45am
8-K
EX-99.1
hvdt44rp0dwk2riq
6 Feb 24
In the Court of Chancery of the State of Delaware
4:47pm
8-K
EX-99.2
vuz9mm q9
6 Feb 24
In the Court of Chancery of the State of Delaware
4:47pm
8-K
EX-10.1
xapcx8bixk szroh9q
5 Feb 24
Entry into a Material Definitive Agreement
5:03pm
8-K
EX-99.1
ifyvb0se
9 Nov 23
Adverum Biotechnologies Reports Third Quarter 2023 Financial Results and Pipeline Highlights
4:07pm